Our network

It is not only our excellent scientists that our success is due to. A broad network, both national and international, and numerous cooperation partners represent a crucial factor in our expertise. Fraunhofer ITEM’s network includes other Fraunhofer Institutes that we collaborate with in Fraunhofer Groups, Alliances and Research Clusters, but also universities, research institutions and companies in Germany and all over the world.

 

Fraunhofer Group for Life Sciences

Prof. Dr. Dr. Gerd Geißlinger, Chairman of the Fraunhofer Group for Life Sciences
© Fraunhofer IME, Krentz Photography Aachen
Prof. Dr. Dr. Gerd Geißlinger, Chairman of the Fraunhofer Group for Life Sciences

The Fraunhofer Group for Life Sciences generates innovative knowledge to seek scientific solutions. The Fraunhofer Institutes pool their expertise to offer a broad spectrum of services and promote cooperation. Expert solutions for your contract research are thus guaranteed.

What characterizes the research performed in the Fraunhofer Group for Life Sciences is its closeness to industrial application, aiming to develop solutions that meet clients’ actual requirements, always with a view to economic efficiency and sustainability. In addition, the institutes also undertake basic research to develop the basis for future applications in industry. The business areas of the Fraunhofer Group for Life Sciences include translational medicine research and biomedical technology, regenerative medicine, healthy foodstuffs, industrial biotechnology, and research aimed at the safety of processes, chemicals, and pesticides.

The Group shows ways of preserving health and the environment in an industrialized world and develops new options for diagnosing and treating diseases in a setting of a more personalized healthcare and for protecting natural resources.

Cluster of Excellence for Immune-Mediated Diseases CIMD

The primary goal of the Fraunhofer Cluster of Excellence for Immune-Mediated Diseases is the translation of innovative ideas and identified targets into individualized therapies for immune-mediated diseases. The collaborating institutes want to bridge the existing gap from research on novel medications to what is actually available to patients.

In forward-looking projects, three Fraunhofer Institutes – Fraunhofer IME, Fraunhofer IZI, and Fraunhofer ITEM – are pooling their expertise, thereby enabling efficient translation. A substantial gain of knowledge in the pathophysiology of immune diseases will thus be generated, innovative targets will be addressed, and new treatment categories in this therapeutic area will be introduced and established.

Cooperation partners (national and international)

 

National

 

  • Abbvie Deutschland GmbH & Co. KG
  • AC Aircontrols GmbH, Kempen
  • Activoris Medizintechnik GmbH, Gemünden (Wohra)
  • Adjutem GmbH, Oldenburg
  • Assay.Works, Regensburg
  • Augsburg University Hospital
  • BASF SE, Ludwigshafen
  • Bayer AG, Berlin and Wuppertal
  • Bielefeld University
  • BioMedVet Research GmbH, Walsrode
  • Boehringer Ingelheim Pharma GmbH & Co. KG
  • Brain AG, Zwingenberg
  • Bundeswehr Hospital, Berlin
  • Cardior Pharmaceuticals GmbH, Hannover
  • Cellex Patient Treatment GmbH, Dresden and Cologne
  • Center for Bioinformatics (CBI), Saarbrücken
  • Center of Allergy & Environment (ZAUM), Munich
  • Ceres GmbH, Lörrach
  • Charité – Universitätsmedizin Berlin
  • Charité Research Organisation, Berlin
  • Cilian AG, Münster
  • CORAT Therapeutics GmbH, Braunschweig
  • Cortec GmbH, Freiburg i. Br.
  • Cytena GmbH, Freiburg i. Br.
  • Desitin Arzneimittel GmbH, Hamburg
  • dysantect, Wiesbaden
  • Essen University Hospital
  • European Aviation Safety Agency (EASA), Cologne
  • European Molecular Biology Laboratory, Heidelberg
  • Federal Environment Agency, Berlin and Dessau
  • Federal Institute for Drugs and Medical Devices (BfArM), Bonn
  • Federal Institute for Occupational Safety and Health (BAuA), Berlin and Dortmund
  • Federal Institute for Risk Assessment (BfR), Berlin
  • Federal Office for Radiation Protection (BfS), Salzgitter
  • Forschungszentrum Jülich
  • Fraunhofer Center for International Management and Knowledge Economy IMW
  • Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig
  • Fraunhofer Institute for Ceramic Technologies and Systems IKTS, Dresden
  • Fraunhofer Institute for Chemical Technology ICT, Pfinztal
  • Fraunhofer Institute for Digital Medicine MEVIS, Bremen
  • Fraunhofer Institute for High-Speed Dynamics, Ernst-Mach-Institut, EMI
  • Fraunhofer Institute for Industrial Mathematics ITWM, Kaiserslautern
  • Fraunhofer Institute for Integrated Circuits IIS, Erlangen
  • Fraunhofer Institute for Intelligent Analysis and Information Systems IAIS, Sankt Augustin
  • Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart and Würzburg
  • Fraunhofer Institute for Laser Technology ILT, Aachen
  • Fraunhofer Institute for Manufacturing Engineering and Automation IPA, Stuttgart
  • Fraunhofer Institute for Manufacturing Technology and Advanced Materials IFAM
  • Fraunhofer Institute for Material and Beam Technology IWS, Dresden
  • Fraunhofer Institute for Mechanics of Materials IWM, Freiburg i. Br.
  • Fraunhofer Institute for Microelectronic Circuits and Systems IMS, Duisburg
  • Fraunhofer Institute for Molecular Biology and Applied Ecology IME, Schmallenberg, Frankfurt/Main and Hamburg
  • Fraunhofer Institute for Reliability and Microintegration IZM, Berlin
  • Fraunhofer Institute for Silicate Research ISC, Aachen
  • Fraunhofer Institute for Surface Engineering and Thin Films IST
  • Fraunhofer Institute of Optronics, System Technologies, and Image Exploitation IOSB, Karlsruhe
  • Fraunhofer Research Institution for Additive Manufacturing Technologies IAPT, Hamburg
  • Fraunhofer Research Institution for Microsystems and Solid State Technologies EMFT, Munich
  • Friedrich Schiller University Jena
  • GEMoaB Monoclonals GmbH, Dresden
  • Genewiz Germany GmbH
  • Georg-August-Universität, Göttingen
  • German Aerospace Center (DLR), Cologne
  • German Center for Infection Research (DZIF)
  • German Center for Lung Research (DZL)
  • German Primate Center, Göttingen
  • Giessen University (JLU)
  • Goethe University Frankfurt, Frankfurt/Main
  • Hannover Medical School
  • Heidelberg University Hospital
  • Helmholtz Center for Infection Research, Braunschweig
  • Helmholtz Zentrum München – German Research Center for Environmental Health, Munich
  • HYpharm GmbH, Bernried
  • IPA – Institute for Prevention and Occupational Medicine of the German Social Accident Insurance at Ruhr-Universität Bochum, Bochum
  • Kiel University
  • KOEHLER eClinical GmbH, Freiburg i. Br.
  • Labor Pachmann, Bayreuth
  • Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures, Braunschweig
  • Leibniz University Hannover
  • Leibniz-Institut für Analytische Wissenschaften – ISAS – e. V., Dortmund
  • Leuphana University Lüneburg
  • Ludwig-Maximilians-Universität München (LMU), Munich
  • LungenClinic Grosshansdorf GmbH
  • Max Planck Institute for Heart and Lung Research, Bad Nauheim
  • MDR Competence, Düsseldorf
  • Merck KGaA, Darmstadt
  • Molecular Machines & Industries MMI GmbH, Eching
  • MT-Consult – Consulting Engineers for Medical Technology, Düsseldorf
  • Nebu-Tec GmbH, Elsenfeld
  • Ostbayerische Technische Hochschule Regensburg
  • Research Center Borstel
  • RWTH Aachen
  • Saarland University
  • SanoLiBio GmbH, Munich
  • Sanum Kehlbeck GmbH & Co. KG, Hoya
  • Schoen Clinic Berchtesgadener Land
  • Technische Universität Braunschweig
  • Technische Universität München (TUM), Munich
  • Telexos GmbH, Weilheim
  • TherapeutAix UG, Aachen
  • TissUse GmbH, Berlin
  • TRAIN – biomedical translation alliance in Lower Saxony, Hannover
  • TWINCORE (center for experimental and clinical research on infections), Hannover
  • Ulm University
  • Universitätsklinikum Erlangen
  • University Hospital Cologne
  • University of Applied Sciences and Arts, Göttingen
  • University of Bonn
  • University of Düsseldorf
  • University of Freiburg
  • University of Leipzig
  • University of Marburg
  • University of Regensburg
  • University of Tübingen
  • University of Veterinary Medicine Hannover, Foundation
  • Vakzine Projekt Management GmbH, Hannover
  • YUMAB GmbH, Braunschweig

 

International

 

  • ACMIT GmbH – Austrian Center for Medical Innovation and Technology, Wiener Neustadt (Austria)
  • AIT Austrian Institute of Technology GmbH, Vienna (Austria)
  • Angle plc, Guildford (UK)
  • AstraZeneca (Sweden)
  • Babeș Bolyai University, Cluj-Napoca (Romania)
  • BioSci Consulting, Maasmechelen (Belgium)
  • cellenion SASU, Lyon (France)
  • CeMM – Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna (Austria)
  • Centro Ceramico Bologna (CCB), Bologna (Italy)
  • Cidetec, San Sebastián (Spain)
  • Daiichi Sankyo, Tokyo (Japan)
  • Demcon (The Netherlands)
  • ETH Zurich, Zurich (Switzerland)
  • European Food Safety Authority (EFSA), Parma (Italy)
  • F. Hoffmann-La Roche AG, Basel (Switzerland)
  • Fundación CIDETEC (CID), San Sebastián (Spain)
  • Genentech, San Francisco, California (USA)
  • GlaxoSmithKline Research and Development Ltd., Brentford (UK)
  • Griffith University, Gold Coast (Australia)
  • HANSABIOMED Ltd., Tallinn (Estonia)
  • Hibercell Therapeutics Inc., Chicago, Illinois (USA)
  • Immunotech SAS, Beckman Coulter Life Scienes, Marseille (France)
  • Instituto de Tecnología Cerámica, Castellón (Spain)
  • IT’IS Foundation, Zurich (Switzerland)
  • Johannes Kepler University Linz, Linz (Austria)
  • Mathys Ltd, Bettlach (Switzerland)
  • McMaster University Medical Center, Hamilton, Ontario (Canada)
  • Medical University of Graz, Graz (Austria)
  • Menarini Silicon Biosystems, Bologna (Italy)
  • Nanoconsult, Meerssen (The Netherlands)
  • Nordic Bioscience, Herlev (Denmark)
  • North Carolina State University (NCSU), Raleigh, North Carolina (USA)
  • Novartis Pharma AG (Switzerland)
  • PAREXEL International (IRL) Limited, Dublin (Ireland)
  • PExA, Gothenburg (Sweden)
  • Poznań University of Medical Sciences, Poznań (Poland)
  • Sahlgrenska University Hospital, Gothenburg (Sweden)
  • Scireq, Montréal, Québec (Canada)
  • Sentinhealth, Paris (France)
  • SeqWell, Beverly, Massachusetts (USA)
  • Université catholique de Louvain, Louvain (Belgium)
  • University Hospital Salzburg (SALK), Salzburg (Austria)
  • University of Alberta, Alberta (Canada)
  • University of Amsterdam, Amsterdam (The Netherlands)
  • University of Basel, Basel (Switzerland)
  • University of Bern, Bern (Switzerland)
  • University of Leeds, Leeds (UK)
  • University of Luxembourg (Luxembourg)
  • University of Southampton, Southampton (UK)
  • US Environmental Protection Agency (EPA), Chapel Hill, North Carolina (USA)
  • Weill Cornell Medicine, Doha (Qatar)
  • Yale University, New Haven, Connecticut (USA)

Active participation in committees

 

Dr. Annette Bitsch

Working committee on probabilistic exposure and risk assessment “Probabilistische Expositions- und Risikoabschätzung”

Expert panel 110 on cooling lubricants “Kühlschmierstoffe” of the Association of German Engineers (VDI) Technical Division 1 “Production Technology and Manufacturing Methods”

Reviewer for international journals published by Elsevier (incl. “Regulatory Toxicology and Pharmacology”)

 

Katharina Blümlein Ph.D.

Working group on analyses in biological materials “Analysen in biologischem Material” of the German Research Foundation (DFG)

 

Prof. Dr. Armin Braun

MD/Ph.D. commission “Molecular Medicine” of the Hannover Medical School

Scientific advisory committee of the German Society for Allergology and Clinical Immunology (DGAKI)

German Center for Lung Research (DZL)

External assessor for international foundations

Reviewer for international journals in respiratory medicine and immunology (incl. “Journal of Allergy and Clinical Immunology”)

 

Dr. Otto Creutzenberg

Reviewer for international journals in particle and fiber toxicology (“Particle and Fibre Toxicology”, “Inhalation Toxicology”)

 

Prof. Dr.-Ing. Theodor Doll

VDE/VDI Society Microelectronics, Microsystems and Precision Engineering GMM, chair of the expert panel on microsystems in medicine/functional surfaces “FA 4.6 Mikrosysteme in der Medizin/Funktionale Oberflächen”

German Society for Biomedical Engineering DGBMT, expert panel on sensor technology ”Sensorik”

Reviewer in the European Commission’s Marie Skłodowska-Curie Actions (MSCA) program, expert in the work packages “Biomedical Technologies” and "Sensors" of the EU Graphene Flagship

ASIIN reviewer for biomedical engineering careers

Guest editor of the journal “Physica Status Solidi (a)”
 

Uta Dörfel

Working groups on GLP analytics “GLP-Analytik” and medical devices “Medizinprodukte” of the German Quality Management Association (GQMA)

 

Dr. Jens Gerdelmann

Working groups on GLP quality assurance/monitoring “GLP: Qualitätssicherung/Überwachung”, GCP quality management “GCP-Qualitätsmanagement”, and medical devices "Medizinprodukte" of the German Quality Management Association (GQMA)

 

Dr. Stefan Hahn 

Chair of the German Chemical Society (GDCh) Division of Environmental Chemistry and Ecotoxicology 

Working committee on chemical risk assessment of the German Chemical Society (GDCh) division of environmental chemistry and ecotoxicology “Umweltchemie und Ökotoxikologie” 

Reviewer for international journals in environmental and exposure sciences (incl. “Integrated Environmental Assessment and Management", "Environmental Science & Technology", "Environmental Toxicology and Chemistry", "Annals of Work Exposures and Health", and "Journal of Exposure Science & Environmental Epidemiology") 

 

Martina Heina

IT division of the International Association for Pharmaceutical Technology (APV)

 

Dr. Martin Hoffmann

Working group on bioinformatics at Comprehensive Cancer Center Ostbayern (CCCO)

External assessor for the Klaus Tschira Foundation (mathematical oncology)

Reviewer for the international journal "Nature Communications"

 

Prof. Dr. Jens Hohlfeld 

External assessor for the German Research Foundation (DFG) 

Steering committee of the research network “Biomedical Research in Endstage And ObsTructive Lung Disease Hannover” (BREATH) within the German Center for Lung Research (DZL) 

Board member of the interdisciplinary allergy center of the Hannover Medical School 

Reviewer for international journals (incl. "American Journal of Respiratory and Critical Care Medicine", "European Respiratory Journal", and "Journal of Allergy and Clinical Immunology") 

 

Dr. Olaf Holz

IABR (International Association of Breath Research) Standardization Focus Group

Reviewer for international journals (incl. "American Journal of Respiratory and Critical Care Medicine", "Journal of Breath Research", "European Respiratory Journal", "PLOS ONE", "Respiratory Research", and "BMC Pulmonary Medicine") 

 

Dr. Kamran Honarnejad

Chair of the Knowledge Content and Delivery Council (KCDC) of the Society for Laboratory Automation and Screening (SLAS) 

Reviewer for the journal "SLAS Discovery"

 

Dr. Rupert Kellner 

Councilor for electronic communication and member of the Executive Board of the European Society of Toxicologic Pathology (ESTP) 

Global Editorial and Steering Committee (GESC) for the initiative "International Harmonization of Nomenclature and Diagnostic Criteria for Lesions in Rats and Mice" (INHAND) 

 

Prof. Dr. Christoph Klein 

External assessor for numerous national and international organizations and foundations: German Research Foundation, German Federal Ministry of Education and Research, Wilhelm Sander Foundation for Cancer Research, ERC, Deutsche Krebshilfe, Christian Doppler Research Association, Dutch Cancer Society, Association for International Cancer Research, EU-FP7, MRC, Cancer Research UK, Kegg-Foundation  

Deputy chairman of the scientific committee of Comprehensive Cancer Center Ostbayern (CCCO) 

Advisory committee of the Pezcoller Foundation-AACR International Award for Cancer Research Committee

Scientific advisory board of the AIRC (Associazione Italiana per la Ricerca sul Cancro) 5x1000 project "Cancer of Unknown Primary (CUP): the archetype of metastatic disease" 

Reviewer for international journals in oncology (incl. “Nature”, “Nature Biotechnology”, “Nature Cell Biology”, “Nature Medicine”, “Cancer Cell”, “Science”, “PNAS”, “American Journal of Pathology”, “Cancer Research”, “Clinical Cancer Research”, “International Journal of Cancer”, “Nucleic Acid Research”, “European Journal of Immunology”, “Lancet Oncology”, “European Journal of Cancer”, “PLOS ONE”, and “Oncotarget”) 

 

Prof. Dr. Wolfgang Koch 

Reviewer for international journals in aerosol physics and aerosol technology (incl. “Journal of Aerosol Science”, “Aerosol Science and Technology”, and “Annals of Work Exposures and Health”)

 

Prof. Dr. Norbert Krug 

Scientific advisory committee of the German Society for Allergology and Clinical Immunology (DGAKI) 

Chair of the Clinical Trial Board of the German Center for Lung Research (DZL) 

Steering committee of the research network “Biomedical Research in Endstage And ObsTructive Lung Disease Hannover” (BREATH) within the German Center for Lung Research (DZL) 

External assessor for the German Research Foundation (DFG) 

Steering committee of the Fraunhofer Research Cluster “Immune-Mediated Diseases” (Fraunhofer CIMD) 

Advisory board of the expertise network “Asthma und COPD” 

Working group “Fraunhofer-Gesellschaft and Deutsche Hochschulmedizin” 

Reviewer for international journals in allergology, immunology, and respiratory diseases

 

Dr. Oliver Licht 

Working group on sustainable chemicals policy “Nachhaltige Chemikalienpolitik” of the 8th Lower Saxony Governmental Commission on sustainable environmental policy and digital change 

German Federal Institute for Risk Assessment (BfR) Committee for Contaminants in the Food Chain; panel on perfluorinated and polyfluorinated alkyl substances “Per- und Polyfluoralkylsubstanzen (PFAS)” 

Expert panel “Basic moduleFraunhofer Group for Life Sciences  and perfluorinated tensides” of the German Federal Institute for Risk Assessment’s MEAL (= meals for exposure assessment and analysis of foods) study within the Total Diet Study (TDS) in Germany 

Working committee on regulatory toxicology “Regulatorische Toxikologie” of the German Society of Toxicology within the German Society of Clinical and Experimental Pharmacology and Toxicology (DGPT) 

Public relations delegate of the German Society of Toxicology

 

Dr. Meike Müller

Network of ombudspersons in Lower Saxony

 

Dr. Neophytos Papamichael 

Working committee on quality management “Qualitätsmanagement im VLS” in the Fraunhofer Group for Life Sciences 

GMP discussion group "GMP-Gesprächskreis" of the Lower Saxony business inspectorate 

 

Dr. Gerhard Pohlmann 

International Society for Aerosols in Medicine (ISAM)

 

Dr. Bernhard Polzer 

External assessor for the Wilhelm Sander Foundation for Cancer Research 

External assessor for the Swiss Cancer League 

Reviewer for international journals in pathology and oncology (“British Journal of Cancer”, “Chemical Science”, “International Journal of Cancer”, “Journal of Histochemistry and Cytochemistry”, “Journal of Visualized Experiments”, “Oncotarget”, “Scientific Reports”, “Expert Reviews of Molecular Diagnostics”, “iScience”, and “Molecular Oncology”) 

 

Prof. Dr. Antje Prasse 

External assessor for the German Research Foundation (DFG) 

Board member of the Scientific Working Group for the Therapy of Lung Diseases (WATL) 

Board member of Deutsche Atemwegsliga e. V. 

Board member of the World Association of Sarcoidosis and other Granulomatous Disorders (WASOG)

Coordinator of the ILD group in the European Reference Network on Respiratory Diseases ERN-LUNG 

Spokesperson for the disease area “DPLD” in the research network “Biomedical Research in Endstage And ObsTructive Lung Disease Hannover” (BREATH) within the German Center for Lung Research (DZL) 

Spokesperson of the Cell Biology Section in the German Respiratory Society (DGP) 

Reviewer for international journals (incl. “American Journal of Respiratory and Critical Care Medicine”, “European Respiratory Journal”, “Journal of Clinical Investigation”, “JCI Insights”, “American Journal of Respiratory and Cell Biology”, and “Thorax”) 

Associate editor of “PLOS ONE”

 

Priv.-Doz. Dr. Susanne Rittinghausen 

Co-optive member of the European Society of Toxicologic Pathology (ESTP) board: representative for nomenclature 

“Guess What” committee of the European Society of Toxicologic Pathology (ESTP) 

Global Editorial and Steering Committee (GESC) for the initiative "International Harmonization of Nomenclature and Diagnostic Criteria for Lesions in Rats and Mice" (INHAND) 

INHAND (International Harmonization of Nomenclature and Diagnostic Criteria) organ working groups “Respiratory System”, “Endocrine System”, “Soft Tissue”, and “Special Senses”, and working group “Apoptosis” 

Ad-hoc working group on inflammatory parameters and inflammatory effects "Entzündungsparameter – entzündliche Effekte" of the DFG Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission) 

Reviewer for the international journals “Toxicologic Pathology” and "Toxicology"

 

Dirk Schaudien Ph.D.

INHAND (International Harmonization of Nomenclature and Diagnostic Criteria) working groups “Non-rodents: Minipig”, "Respiratory System", and "Skeletal Tissues (Bones, Joints, and Teeth)" 

“Pathology 2.0” committee of the European Society of Toxicologic Pathology (ESTP) 

“Guess What” committee of the European Society of Toxicologic Pathology (ESTP) 

Examination board of the European College of Veterinary Pathology 

 

Dr. Stefanie Scheffler

Working group on e-cigarettes and liquids for e-cigarettes of the DIN Standards Committee "Food and Agricultural Products" 

 

Dr. Sven Schuchardt 

Treasurer of the German Society for Metabolome Research 

Working group on air analyses “Luftanalysen” of the German Research Foundation (DFG) 

Leibniz-Institut für Analytische Wissenschaften – ISAS – e. V. (Leibniz Institute for Analytical Sciences) 

Scientific committee for the EU project FACTS (investigations to find FACTS on the subject of aircraft cabin air quality) 

 

Dr. Florian Schulz

DFG Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area (MAK Commission): working group on the definition of threshold limit values for dusts 

Committee on Hazardous Substances (AGS) under the German Federal Minister of Labor and Social Affairs: Subcommittee III for the evaluation of hazardous substances “Gefahrstoffbewertung”, working groups on metals and fibers/dust 

Advisory Board of the European Certification Board for Mineral Wool Products (EUCEB) 

External expert in the quality control committee of the mineral wool quality assurance association "RAL-Güteqemeinschaft Mineralwolle" (GGM)

 

Dr. Katherina Sewald 

Steering group of the workshop “Respiratory Toxicity” 

German Center for Lung Research (DZL) 

Executive committee on basic research in the research network “Biomedical Research in Endstage And ObsTructive Lung Disease Hannover” (BREATH) within the German Center for Lung Research (DZL)

Mentor in the Fraunhofer career program for female scientists TALENTA 

External assessor for international research grants 

Reviewer for the international journals “Toxicology Letters”, “Toxicology in vitro”, “Nanotoxicology”, “ATOX”, and “PLOS ONE” 

 

Prof. Dr. Lena Wiese

Special interest group "Digital Health" and working group "Data Science and Data Engineering" of the German Informatics Society 

 

Dr. Dorothee Winterberg

Working group "Respiratory Toxicology" of the German Society of Toxicology (DGT)

Association of Inhalation Toxicologists (AIT)

German Center for Lung Research (DZL)

 

Dr. Sabine Wronski 

Reviewer for the international journal “European Respiratory Journal”

 

Prof. Dr. Holger Ziehr 

Association of German Engineers (VDI) committee “Technical Good Manufacturing Practice” 

GMP discussion group "GMP-Gesprächskreis" of the Lower Saxony business inspectorate 

Center for Pharmaceutical Process Engineering (PVZ) at Technische Universität Braunschweig 

BioPharma-Translationsinstitut e. V. 

 

Dr. Christina Ziemann 

Chair of the working group on statistics of the German Society for Environmental Mutation Research (GUM) 

Working group “Genotoxicity” of the DIN Standards Committee "Water Practice“ 

Working group on carcinogenesis “Carcinogenese” of the German Society of Toxicology 

OECD pool of experts of the German Federal Institute for Risk Assessment 

External assessor for applications submitted to the German Federal Environmental Foundation 

German Pharm-Tox Summit program committee 

Reviewer for international journals in genetic toxicology, nanomaterials, and quartz (incl. “Regulatory Toxicology and Pharmacology”)

Publicly funded research projects

 

National

 

Bavarian Ministry of Economic Affairs, Regional Development and Energy

Further development of Fraunhofer ITEM in Regensburg

 

Bavarian Research Foundation

Project: Inhibiting COVID‐19 N-protein-mediated infectivity

HTP screening to identify inhibitors of N-protein function to interfere with genome packaging of SARS-CoV-2

 

Bayern Innovativ, funding program "Biomedical Engineering"

Project: KrEiBl

Method for blood-based cancer diagnosis at the single-cell level: molecular analysis of single cells

 

Deutsche Krebshilfe (German Cancer Aid) – Priority Program “Translational Oncology”

DETECT CTC: Detection and molecular characterization of circulating tumor cells and cell-free nucleic acids in advanced breast cancer in the context of tumor heterogeneity

 

DFG – German Research Foundation

Selection and adaptation during metastatic cancer progression. FOR 2127, project no. 242727105

Designing nanoparticle-based inhaled antibiotics for the treatment of cystic fibrosis associated biofilms and infections and in vivo studies in a rat model. Project no. 256755002

Identification of tumor-specific peptides for adjuvant immunotherapy of melanoma patients without distant metastasis. Project no. 320058447

 

Federal Environment Agency

Relevance of physiological and anthropometric parameters for the standardization and assessment of human biomonitoring results. R&D project 3716 62 214 0

 

Federal Institute for Occupational Safety and Health (BAuA)

Mode of toxic action of nanocarbons. Research project F 2376

 

Federal Joint Committee/Innovation Committee

PTmHBP – Practicability testing of the magistral production of bacteriophages for the therapy of septic infections of the lower extremity (PhagoFlow)

 

Federal Ministry for Economic Affairs and Energy, central innovation program for SMEs

Development of an ex-vivo rat lung model for quality assurance of surfactant batches without the need to simulate asphyxia

 

Federal Ministry of Education and Research (BMBF) action plan for individualized medicine, funding area “Innovations for individualized medicine”

Collaborative project: TurbiCAR

UniCAR-based treatment of CD123-positive lymphoblastic leukemia – subproject “Production of the anti-CD123 target module”

 

Federal Ministry of Education and Research (BMBF) framework program “Gesundheitsforschung” (health research)

Collaborative research project: 4-IN

Insect-derived inhalable inhibitors of bacterial virulence for treating lung infections

 

Collaborative research project: Phage4Cure

Developing bacteriophages as approved therapy against bacterial infections

 

Collaborative research project: TPHiPAH

Tryptophan hydroxylase inhibitors as novel therapeutics for pulmonary arterial hypertension

 

Federal Ministry of Education and Research (BMBF) funding program “Alternatives to Animal Testing”

Project: InhalAb

Alternative models for testing of inhalable antibiotics

 

Project: Inhal-Prädikt

Universally applicable model for prediction of the local efficacy of (inhaled) anti-infectives in the lungs

 

Federal Ministry of Education and Research (BMBF) funding program “Erforschung von Covid-19 im Zuge des Ausbruchs von Sars-CoV-2” (research on Covid-19 in response to the Sars-CoV-2 outbreak)

RENACO – Repurposing of Nafamostatmesylat for Covid-19 treatment

 

Federal Ministry of Education and Research (BMBF) funding program “Ersatz und Ergänzungsmethoden zum Tierversuch” (alternatives and complements to animal experiments)

Project: ExITox2 – Explain Inhalation Toxicity 2

Animal-free mechanism-based toxicity testing – predict toxicity after repeated-dose inhalation exposure by using a read-across approach

 

Federal Ministry of Education and Research (BMBF) funding program “Establishment of Industry-in-Clinic Platforms for the Development of Innovative Medical Devices”

Cooperation of Hannover Medical School, Fraunhofer ITEM and other stakeholders in the field of biomedical engineering, aimed at offering the competencies available in Hannover as a one-stop shop with pooled services

 

Federal Ministry of Education and Research (BMBF) funding program FlexMax: flexible active sensor matrix for medical applications

Use of sensor arrays in two different biomedical engineering systems:

sub-project "Sensorgesteuerte Atmungsüberwachung, Atmungstriggerung und Inhalation bei Frühgeborenen" (sensor-controlled breath monitoring, breath triggering, and inhalation in preterm infants)

 

Federal Ministry of Education and Research (BMBF) funding program "In-vitro Challenge"

ImmunAVATAR: Make your immune system great again (exploratory phase)

 

Federal Ministry of Education and Research (BMBF) funding program “Innovative Stammzelltechnologien für die individualisierte Medizin” (innovative stem cell technologies for individualized medicine)

Project: iCARE

Induced pluripotent stem cells for clinically applicable heart repair

 

Federal Ministry of Education and Research (BMBF) funding program "KMU-innovativ: Medizintechnik" (innovative SMEs: biomedical engineering)

Collaborative project: CTCbySCP

Development of a single cell printer-based method for marker-independent quantification and isolation of vital circulating tumor cells for diagnosis and personalized therapy

 

Federal Ministry of Education and Research (BMBF) funding program "NanoCare4.0 – application-safe material innovations"

Project: MetalSafety

Development of evaluation concepts for fibrous and granular metal compounds: bioavailability, toxicological efficacy profiles and comparative in vitro, ex vivo and in vivo studies

 

Project: NanoINHAL 

In-vitro test methods for airborne nanomaterials to investigate toxic potential and uptake after inhalation exposure using innovative organ-on-a-chip technology

 

Federal Ministry of Education and Research (BMBF), German Centers for Health Research (DGZ)

German Centre for Cardiovascular Research (DZHK):
Single-cell RNA sequencing in iPSC-derived nodal and atrial cells from patients with atrial fibrillation

German Center for Lung Research (DZL):
Allergy and asthma
Chronic obstructive pulmonary disease (COPD)
Diffuse parenchymal lung diseases (DPLD)

 

Federal Ministry of Health

ELISE – Ein Lernendes und Interoperables, Smartes Expertensystem für die pädiatrische Intensivmedizin (a learning and interoperable, smart expert system for pediatric intensive-care medicine)

 

Federal Office for Radiation Protection

Childhood leukemia – influence of the immune system on the development of the disease (experimental study in a suitable animal model)

 

Lower Saxony Ministry of Science and Culture

Collaborative project: FibroOmics

Translating Omics studies into clinically relevant insights for lung fibrosis patients

 

International

 

EU project: ERA-Net TRANSCAN

Analysis of tumor evolution and identification of relapse-initiating tumor cells in non-small cell lung carcinoma

 

EU project: eTranSafe (IMI)

Enhancing translational safety assessment through integrative knowledge management

 

EU project: Eurostars TARGIT

Development of next-generation treatment for allergies: targeted glycan-allergen immunotherapy

 

EU project: Immune Safety Avatar (imSAVAR)

Nonclinical mimicking of the immune system effects of immunomodulatory therapies

 

EU project: Marie Skłodowska-Curie Innovative Training Networks, Magicbullet :: Reloaded (HORIZON 2020)

Development and employment of approaches for selective, targeted delivery of a panel of anticancer drugs for directed tumor therapy

 

EU project: MDOT (Medical Device Obligations Taskforce)

Establishment of a digital platform for simplified conformity assessment and testing of medical devices, including three demonstrator technologies: Inhalation technology, 3D-printed neural implantats, and coatings for orthopedic prostheses

 

EU project: PREMIER (IMI)

Prioritization and risk evaluation of medicines in the environment

 

EU project: RealWorld4Clinic (EIT Health innovation project)

AI-powered health monitoring for clinical research and cardiology

 

EU project: REMADYL (HORIZON 2020)

Removal of legacy substances from polyvinylchloride (PVC) via a continuous and sustainable extrusion process

 

EU project: REMEDIA – RElation exposoME DIseAse

Impact of exposome on the course of lung diseases

 

EU project: TBMED
An open innovation test bed for the development of high-risk medical devices

Translation of the quality-by-design approach of the pharmaceutical industry to biomedical engineering, using several medical devices as examples: bone defect reconstruction materials, keratoprosthesis, and nanoparticles for cancer treatment

 

EU project: ToxRisk (Horizon 2020)

An Integrated European ‘Flagship’ Programme Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st century

University teaching activities

 

Prof. Dr. Armin Braun

TRAIN Academy: professional education program "Translational Research & Medicine: From Idea to Product” (lecturer and person in charge of Module 6 “Preclinical development”)

Hannover Medical School: lectures in the MD/Ph.D. program “Molecular Medicine”

Lower Saxony International Summer Academy in Immunology at the Hannover Medical School: lecture on neuroimmune interactions in allergic asthma in the session “Lung Inflammation, Asthma, Allergy”

 

Sven Cleeves

Kaiserslautern University of Applied Sciences: lecture about precision-cut lung slices as part of the series of lectures "Replacement and Reduction of Animal Experiments" for master students

 

Dr. Otto Creutzenberg

University of Leipzig: lecture on inhalation toxicology in the postgraduate course “Toxicology and Environmental Protection”

Universities of Jena/Erfurt, Institute for Pharmacology and Toxicology: lecture on exposure methods/toxicokinetics within the DGPT course “Fundamentals of organ toxicology and organ pathology”

 

Prof. Dr.-Ing. Theodor Doll

Leibniz University Hannover: lecture on polymers for implant production in the degree course “Biomedical Engineering”; two lectures ("General introduction to regulatory affairs" and "Standards in biomedical engineering") as part of the series of lectures "Introduction to regulatory affairs and quality management in biomedical engineering"

Hannover Medical School: postgraduate training course in nanomedicine

Jade University of Applied Sciences Wilhelmshaven: lecture on biomechanics, breathing and neuro-rehabilitation in the degree course “Medical Technology“

TRAIN Academy: lectures on economic aspects in implant development

 

Dr. Ulrich Froriep

Leibniz University Hannover: lecture ("Digitalization in biomedical engineering") as part of the series of lectures "Introduction to regulatory affairs and quality management in biomedical engineering"

 

Prof. Dr. Edward Geissler

University of Regensburg: lecture on methods in transplantation immunology; practical exercises with experimental animal models for research on  tumor angiogenesis; laboratory course for staff and Ph.D. students; lab meeting with Ph.D. students; Journal Club

 

Dr. Jens Gerdelmann

TRAIN Academy: lectures on quality management, Good Laboratory Practice (GLP), and clinical  testing of medical devices (modules 2.1, 2.6 and 5.8)

Leibniz University Hannover: lecture "Quality management (introduction)" as part of the series of lectures "Introduction to regulatory affairs and quality management in biomedical engineering"

Hannover Biomedical Research School (HBRS) at the Hannover Medical School: workshop “Introduction to GLP and GMP”

Hannover Medical School, Ph.D. programm "Regenerative Science": seminar and tutorial "Quality Management"

 

Dr. Markus Heine

Technische Universität Braunschweig:  lectures on applied and technical biochemistry incl. hands-on training

 

Prof. Dr. Jens Hohlfeld

Hannover Medical School: lectures on allergic respiratory diseases

 

Dr. Kamran Honarnejad

University of Regensburg: seminar in pathology in the degree course “Molecular Medicine”

 

Dr. Stefan Kirsch

University of Regensburg: lectures and hands-on training in molecular oncology in the degree course “Molecular Medicine”; hands-on training in database research in the degree course “Computational Science”

 

Prof. Dr. Christoph Klein

University of Regensburg: lectures in pathology and molecular oncology in the degree course “Molecular Medicine”; seminar and hands-on training in molecular oncology; lectures on pathology in the degree course “Human Medicine”; methodology seminar "Experiment and analysis" for Ph.D., master, and bachelor students of the Chair of Experimental Medicine and Therapy Research

Ostbayerische Technische Hochschule Regensburg: seminar "How does metastatic dissemination take place?" in the degree course “Medical Information Technology”

 

Dr. Oliver Licht

Leuphana University Lüneburg: lectures on toxicology and ecotoxicology in the professional Master's program "M.Sc. Sustainable Chemistry"

RWTH Aachen: lecture on regulatory toxicology and risk assessment in the degree course "M.Sc. Ecotoxicology"

 

Dr. Gerhard Pohlmann

TRAIN Academy: lectures on economic aspects in implant development and in Module 6 “Preclinical Development of Medical Devices”

 

Dr. Bernhard Polzer

University of Regensburg: lectures on molecular oncology in the degree course “Molecular Medicine”; hands-on training in molecular oncology

 

Prof. Dr. Antje Prasse

Hannover Medical School: main lectures on internal medicine in the degree course "Human medicine"; seminar on pulmonological topics for interns in the degree course "Human medicine"; lectures on translational research in pulmonoloy within the REBIRTH/KFO311 Ph.D. student program

 

Prof. Dr. Tobias Pukrop

University of Regensburg: lecturs on pathology and molecular oncology the degree course “Molecular Medicine”; hands-on training in molecular oncology 

 

Priv.-Doz. Dr. Susanne Rittinghausen

University of Veterinary Medicine Hannover, Foundation: seminars in toxicological pathology

 

Dr. Anton Roß

Hamburg University of Applied Sciences: lectures in Good Manufacturing Practice (GMP)

 

Dirk Schaudien Ph.D.

University of Veterinary Medicine Hannover, Foundation: lectures and seminars in special and toxicological pathology

 

Dr. Katherina Sewald

Hannover Medical School: lectures on allergy and asthma, analgesics, Parkinson's disease and schizophrenia in the degree courses “Biomedicine” and "Biochemistry"; laboratory course in biomedicine; laboratory course in biochemistry: immunology

RWTH Aachen: lectures on immunotoxicology in the vocational degree course Laboratory Animal Science M. Sc.”

TRAIN Academy: lectures on immunotoxicology

 

Dr. Nataşa Stojanovic

University of Regensburg: seminar in pathology in the degree course “Molecular Medicine”

 

Dr. Henning Weigt

TRAIN Academy: lectures on “Preclinical development, phases, costs, and quality assurance”

 

Dr. Christian Werno

University of Regensburg: lectures on pathology and molecular oncology in the degree course “Molecular Medicine”; hands-on training in molecular oncology

Ostbayerische Technische Hochschule Regensburg: seminar "How does metastatic dissemination take place?" in the degree course “Medical Information Technology”

 

Prof. Dr. Holger Ziehr

RWTH Aachen: lectures on “Regulatory Affairs”

Technische Universität Braunschweig: lectures on applied and technical biochemistry